Microalbuminuria is an independent prognostic marker in patients with chronic heart failure

Arquivos Brasileiros de Cardiologia

Volumn 98, Issue 1, 2012, Pages 62-68

  Villacorta, Humberto ^a   Ferradaes, Paula de Vilhena ^a   Mesquita, Evandro Tinoco ^a   da Nóbrega, Antônio Cláudio Lucas ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Albuminuria; Heart failure; Kidney diseases; Prognosis

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MALE; MICROALBUMINURIA; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; URINE;

ALBUMINURIA; BIOLOGICAL MARKERS; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME;

EID: 84857188432     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000120     Document Type: Article

References (25)

1. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002;61(6):2165-75.
2. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factor and cardiovascular morbidity. J Intern Med. 2001;249(6):519-26.
3. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation. 2005;112(7):969-75.
4. Diercks GF, van Boven AJ, Hillege HL, Janssen WN, Kors JA, de Jong PE, et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population: The PREVEND (Prevention of REnal and Vascular ENdstage Disease) Study. Eur Heart J. 2000;21(23):1922-7.
5. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus: Risk Factor Intervention Study Group. Am J Cardiol. 1997;80(2):164-9.
6. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease. Nephrol Dial Transplant. 2008;23(12):3851-8.
7. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421-6.
8. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423-9.
9. Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension. 2005;46(1):33-7.
10. Capes SE, Gerstein HC, Negassa A, Yusuf S. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction. Diabetes Care. 2000;23(3):377-80.
11. Jose P, Tomson C, Skali H, Rouleau J, Braunwald E, Arnold JM, et al. Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. J Am Coll Cardiol. 2006;47(8):1725-7.
12. van de Wal RMA, Asselbergs FW, Plokker HWT, Smilde TDJ, Lok D, van Veldhuisen DJ, et al. High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail. 2005;11(8):602-6.
13. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009;374(9689):543-50.
14. Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, et al. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure Trial. Circ Heart Fail. 2010;31):65-72.
15. Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, et al. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007;116(23):2687-93.
16. Carrie BJ, Hilberman M, Schroeder JS, Myers BD. Albuminuria and the permselective properties of the glomerulus in cardiac failure. Kidney Int. 1980;17(4):507-14.
17. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, de Zeeuw D, de Jong PE. Urinary albumin excretion is associated with renal function abnormalities in a nondiabetic population. J Am Soc Nephrol. 2000;11(10):1882-8.
18. Kravaritou M, Thanopoulou A, Karamanos B, Kofinis A, Noutsou M, Spanou E, et al. Evidence that even "normal" albuminuria may denote incipient GFR reduction in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009;85(3):317-21.
19. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Urinary neuthrophile gelatinase-associated lipocalin (NGAL), a marker of tubular damage is increased in patients with chronic heart failure. Eur J Heart Fail. 2008;10(10):997-1000.
20. Bocchi EA, Marcondes-Braga FG, Ayub-Ferreira SM, Rohde LE, Oliveira WA, Almeida DR, et al.; Sociedade Brasileira de Cardiologia. III Diretriz brasileira de insuficiência cardíaca crônica. Arq Bras Cardiol. 2009;92(1 supl.1):3-70.
21. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119 (12 Suppl 1):S3-S10.
22. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53(7):582-8.
23. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced heart failure. J Am Coll Cardiol. 2009;53(7):589-96.
24. Giannattasio C, Achilli F, Grappiolo A, Failla M, Meles E, Gentile G, et al. Radial artery-flow mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment. Hypertension. 2001;38(6):1451-5.
25. Varin R, Mulder P, Tamion F, Richard V, Henry JP, Lallemand F, et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin. Circulation. 2000;102(3):351-6.